Income statement
USD
Annual
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 136M | 119M | 0 | 0 | 0 |
| Gross Profit | 85M | 59M | 0 | 0 | 0 |
| Operating Income | -33M | -101M | -3M | -527K | -7K |
| EBITDA | -33M | -101M | -2M | 4M | -7K |
| Net Income | -37M | -103M | -2M | 3M | -7K |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$8.81
-3.40% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Crescent Acquisition Corp. (CRSA) is a Financial Services stock with a market cap of $817.65M. The stock last traded around $8.81. Baseline metrics include revenue growth of +14.1%, EPS growth of +68.2%, a dividend yield of 0.0%. What stands out right now is revenue +14.1%, EPS +68.2%, free cash flow 0.0% with operating margin -24.4% and ROIC -21.0%. Valuation is more restrained than many high-expectation growth names at price/sales 2.6. Stock Foundry combines CRSA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CRSA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CRSA Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CRSA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$6.6K
-100.2% YoY
Free Cash Flow
-$185.7K
+85.2% YoY
Revenue Growth
+14.1%
EPS Growth
+68.2%
Gross Margin
62.5%
Net Margin
-27.6%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 136M | 119M | 0 | 0 | 0 |
| Gross Profit | 85M | 59M | 0 | 0 | 0 |
| Operating Income | -33M | -101M | -3M | -527K | -7K |
| EBITDA | -33M | -101M | -2M | 4M | -7K |
| Net Income | -37M | -103M | -2M | 3M | -7K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2020 | 2019 | 2018 |
|---|---|---|---|
| Cash & Equivalents | 307K | 1M | 45K |
| Total Assets | 254M | 255M | 523K |
| Total Liabilities | 11M | 10M | 506K |
| Shareholder Equity | 243M | 245M | 17K |
| Total Debt | 0 | 0 | 263K |
| Net Debt | -307K | -1M | 218K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
186K
+85.2% YoY
Capital Expenditures
0
Free Cash Flow
186K
+85.2% YoY
Key ratios
Gross Margin
62.5%
Operating Margin
-24.4%
Net Margin
-27.6%
ROE
-33.7%
Debt / Equity
0.62x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.